EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Advancing Biopharmaceutical Innovation Through Cell Encapsulation and Biomimetic Therapeutic Systems
My interest in biopharmaceutical engineering began during my senior year as an undergraduate For my capstone project I worked on the encapsulation of...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
Manufacturing Strategies for GLP-1s, Peptides, and High-Demand Biologics
Few product classes have humbled operational forecasting the way incretin therapies have Demand curves that boards approved as aggressive were overtaken within quarters Sites built for one modality found themselves supplying another And through it all the same question was asked in the same unhelpful form how many kilograms can we make
-
Techno Trends
FDA Authorises Aletta for Autonomous Blood Collection
The US Food and Drug Administration FDA has authorised Aletta the first standalone robotic device designed to collect blood from a patients arm without handson operator intervention
-
Projects
Cambrex Expands Milan R&D Operations With US$30 Million Investment
Cambrex has begun construction of a new research and development facility at its Profarmico Milano site in Italy supported by a US million investment The initiative is designed
-
Research Insights
CAVE-Onc: Graph-constrained agentic validation for cross-domain contradictions in CDISC oncology submissions
The CDISC Rules Engine CORE provides industrystandard validation for Study Data Tabulation Model SDTM submissions yet its imperative domainscoped architecture cannot express crossdomain contradictions
-
White Papers
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys complexity
TOP ARTICLES
-
1
Pharma Display Advertising: Boost Leads & Webinar Registrations Instantly
Kate Williamson
Pharma display advertising provides pharmaceutical organizations with a high level of targeting healthcare and industry audiences with the help of targeted digital placements. Through pharmaceutical d...
-
2
Bioprocessing & Bioproduction In-Depth Focus 2025
Kate Williamson
The bioprocessing and bioproduction sector of 2025 experiences fundamental changes through continuous processing and digitalization and sustainability and advanced therapeutic advancements. Advances i...
-
3
Unlocking Advanced Therapies with Automation & Digital Tech
Kate Williamson
The manufacturing process of advanced therapies undergoes change through automation and digital technologies because these methods help achieve better precision, scalability and compliance. Personaliz...
-
4
The Commercial Future of Personalized mRNA Cancer Vaccines
Lakshmi
Personalized mRNA cancer vaccines are approaching the point at which their future will be decided by commercial architecture rather than immunology. Manufacturing a distinct medicine for every patient...
-
5
10 Reasons to Consider Placebo Use in Clinical Trials
Kate Williamson
Clinical trials are pivotal for medical advancements, and the use of placebos is a critical element. This exploration outlines ten reasons for the essential role of placebos, emphasizing their contrib...
press releasesRead more...
Exegenesis Bio and Modalis Collaborate to Advance MDL-201 for Duchenne Muscular Dystrophy
Exegenesis Bio and Modalis Therapeutics Corporation TOKYO Modalis today announced that they have signed a research collaboration and license agreement to advance MDL
Nutromics receives FDA Breakthrough Device Designation
Nutromics is building a wearable labonapatch for continuous molecular monitoring Today the company has announced that the FDA has granted Breakthrough Device Designation BDD for its first product in development a wearable for vancomycin therapeutic drug monitoring
EpilepsyGTx and Viralgen collaborate to advance AAV gene therapy programme for epilepsy ahead of first-in-human trial
EpilepsyGTx a biotechnology company developing gene therapies for refractory epilepsy and Viralgen a leading contract development and manufacturing organization CDMO specialising in recombinant
Revvity to Acquire Human Cell Design to Advance Human-Relevant Cell Models for Metabolic Disease Drug Discovery
Revvity Inc NYSE RVTY today announced it has entered into a definitive agreement to acquire Human Cell Design HCD a Francebased biotechnology company specializing in human cell models and preclinical research solutions
Events Read more...
14 - 16
Sep 202614 - 15
Sep 202616th American DDF Summit
Omni Boston Hotel at the Seapo...
15 - 17
Sep 2026COPD Drug Development Summit 2026
Street, Boston, MA 02210, USA
21 - 23
Sep 2026Cell & Gene Therapy World Conference
Miami, Florida, USA
21 - 23
Sep 2026Cancer R&D World Conference
Hilton Garden Inn Miami Dolphi...
22 - 23
Sep 2026PDA Advanced Parenteral Therapeutics & Quality
Illume Hotel Taipei, Taiwan
22 - 24
Sep 2026InsurInnovator Connect Asia
Singapore
28 - 02
Sep 2026Discovery on Target 2026
Boston, MA, USA
LATEST NEWSRead more...
ABEC Opens New Manufacturing Facility in North Carolina
ABEC has opened a new manufacturing facility in Wilson North Carolina expanding its global production network and strengthening support for the growing biopharmaceutical industry
Biora Therapeutics to Initiate First Human Study of BioJet Oral Biologic Delivery Capsule
Biora Therapeutics plans to begin its first human clinical study of BioJet an ingestible capsule designed to deliver medicines directly into the small intestine using liquid jet technology
Lotus Neuro launches to advance targeted therapies across the blood-brain barrier
Lotus Neuro a clinicalstage biotechnology company focused on neurological diseases has announced its public launch The company combines focused ultrasound with existing therapeutic approaches to improve the delivery of medicines across the bloodbrain barrier BBB
Sobi receives US FDA Fast Track designation for pacritinib in VEXAS syndrome
Sobi North America the North American affiliate of Swedish Orphan Biovitrum Sobi has announced that the US Food and Drug Administration FDA has granted Fast Track designation to pacritinib for the treatment of VEXAS syndrome
Sernova and Seraxis to Merge and Form BetaNova Biotherapeutics for Type 1 Diabetes Cell Replacement
Sernova Biotherapeutics Inc and Seraxis Holdings Inc have entered into a definitive merger agreement to combine their technologies and create BetaNova Biotherapeutics a clinicalstage biotechnology
RiboX Therapeutics Receives FDA RMAT Designation for RXRG001
RiboX Therapeutics has received Regenerative Medicine Advanced Therapy RMAT designation from the US Food and Drug Administration FDA for RXRG an investigational treatment
